Children's Aid Societies: Differential Response and Wraparound Prevention Trial
The purpose of this study is to assess the cost-effectiveness of this Differential Wraparound model, in 5 Children's Aid Societies within Hamilton-Niagara Region, in preventing maltreatment cases from either becoming ongoing protection cases, or the children ending up in out-of-home of out-of community placements, as well as reducing the amount of time in Children's Aid Society care as compared...
Brief Summary
Official Title: “The Comparative Effects and Expense of Augmenting Usual Children's Aid Society (CAS) Care With a Regional Differential Response and Wraparound Prevention Service for Children”
The purpose of this study is to assess the cost-effectiveness of this Differential Wraparound model, in 5 Children's Aid Societies within Hamilton-Niagara Region, in preventing maltreatment cases from either becoming ongoing protection cases, or the children ending up in out-of-home of out-of community placements, as well as reducing the amount of time in Children's Aid Society care as compared to usual Children's Aid Society risk assessment and protection service alone.
- Study Type: Observational
- Study Design: Observational Model: Case Control, Time Perspective: Prospective
Detailed Clinical Trial Description
The number of children in child welfare care has increased from 10,000 in the early 1990s to over 18,000. Ontario spends over $1.1 billion a year on direct child welfare services, more than twice as much as spent in the late 1990s, with the majority of these resources spent on investigation instead of treatment. In response to this situation, Differential Response models, sometimes called alternative, multiple or integrated system responses, have been implemented in the US, Australia and Canada and are all at the beginning stages of systematic evaluation. These models will help prevent maltreatment cases from becoming ongoing protection cases, or the children ending up in out of home or community placements, and reduce the amount of time in Children's Aid Society care. This research will show the benefits and costs of a Differential Response approach to Children's Aid Society care, specifically in the Hamilton-Niagara Region
Arms, Groups and Cohorts in this Clinical Trial
- : Children's Aid Societies
- Comparing differential response (Wraparound) with usual care
Outcome Measures for this Clinical Trial
Primary Measures
- To measure the characteristics of families and their children and comparisons between usual care versus differential response
- Time Frame: Follow-up at 1 year and 2 years
Safety Issue?: Yes
- Time Frame: Follow-up at 1 year and 2 years
Secondary Measures
- Follow up measures at 1 year and 2 year follow ups including measuring whether differential response is happening
- Time Frame: 6 months after facilitator is assigned
Safety Issue?: Yes
- Time Frame: 6 months after facilitator is assigned
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Parent of children and youth, living in Hamilton and surrounding areas.
- Newly referred substantiated cases going on to protective services.
- English & non-English speaking.
Exclusion Criteria:
- Safety threat
- Non-substantiated cases not going to protective services.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 1 Year
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Hamilton Children's Aid Society Other
Overall Clinical Trial Officials and Contacts
Dominic Verticchio Principal Investigator Children's Aid Society
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00559208
Study ID Number: 06-103
ClinicalTrials.gov Identifier: NCT00559208
Health Authority: Canada: Ethics Review Committee
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00559208
